Last week, a U.K. regulatory authority announced that it had granted permission to a London research team to edit the genomes of human embryos. The move, by the U.K.'s Human Fertilisation and Embryology Authority, has led some people to ask whether the U.S. National Institutes of Health might follow suit and start funding gene-editing research on human embryos. The answer is almost certainly no.